logo
  

United Technologies Increases 2016 Adj. EPS, Organic Sales Outlook - Quick Facts

United Technologies Corp. (UTX) announced the company now expects slightly higher organic sales growth and increased the low end of its adjusted EPS outlook by ten cents and now expects 2016 EPS of $6.55 to $6.60, up from prior guidance of $6.45 to $6.60. Analysts polled by Thomson Reuters expect the company to report profit per share of $6.58. Analysts' estimates typically exclude special items.

The company continues to expect total sales in a range of $57 to $58 billion, year over year growth of 2 to 3 percent, including organic sales growth of 2 to 3 percent up from 1 to 3 percent.

UTC CEO Gregory Hayes, said: "Organic growth across the aerospace units and solid cash generation across all businesses, even with continuing investments in the aerospace related ramp-up, give us high confidence in meeting our commitments to shareholders."

Third-quarter GAAP EPS was $1.74, up 8 percent versus the prior year and included 2 cents of net restructuring and other significant items. Adjusted EPS was $1.76, up 5 percent versus the prior year. Sales were $14.4 billion, an increase of 4 percent, driven by 5 points of organic growth partially offset by 1 point of adverse foreign exchange.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The U.S. Consumer Product Safety Commission or CPSC has announced recalls including earmuffs, racer car toys, log splitters and cylinder kits, hampshire cribs, and air rifles, citing various reasons. 3M Co. has recalled Peltor X4 Series Earmuffs citing risk of overexposure to loud noise and sound, while Santa Monica, California -based JAKKS Pacific Inc. has called back children's Mario Kart... Lincoln Park, New Jersey -based ConSup North America Inc. is recalling around 85,984 pounds of ready-to-eat or RTE sliced prosciutto ham product produced in Germany without the benefit of equivalent inspection, the U.S. Department of Agriculture's Food Safety and Inspection Service or FSIS announced. French drug major Sanofi reported Thursday weak profit in its first quarter, despite higher net sales. The company also maintained its fiscal 2024 outlook. Sanofi shares were gaining around 4 percent in Paris trading as well as in pre-market activity on the Nasdaq.

A busy week for economics saw the release of first quarter growth figures for the U.S. economy and the interest rate decision in Japan. Read our stories to find out why the GDP data damped market sentiment in the U.S. and what were the signals given out by the Bank of Japan. Other news this week included new home sales data and jobless claims figures from the U.S., and the latest purchasing managers' survey results for the Eurozone.

View More Videos
Follow RTT